Barriers to Implementing SMART for Asthma in Pediatric Primary Care

OBJECTIVES: To characterize awareness, use, and perceived barriers to implementing single maintenance and reliever therapy (SMART) in primary care for children aged 5 years or older, hypothesizing high clinician awareness but limited use due to multilevel clinician-, system-, and caregiver barriers. METHODS: We conducted a sequential explanatory mixed-methods study among pediatric primary care clinicians within a practice-based research network. Clinicians completed a survey assessing SMART awareness, prescribing practices, and perceived barriers, guided by the Consolidated Framework for Implementation Research (CFIR) 2.0. Semistructured interviews were conducted with purposively sampled clinicians to explore factors influencing SMART implementation. Qualitative data were analyzed using an inductive-deductive approach and mapped to CFIR 2.0 constructs. RESULTS: Fifty-two clinicians (27.5%) completed the survey, and 24 completed interviews. Awareness of SMART was universal, but use remained limited among eligible pediatric patients, particularly younger children. Clinicians viewed SMART as effective and guideline-concordant but described multilevel barriers to routine implementation. Qualitative analysis identified 3 themes: (1) SMART is clinically advantageous but challenging to operationalize; (2) system-level and workflow barriers, including insurance coverage and prior authorization requirements, constrain adoption; and (3) caregiver resistance impedes deimplementation of short-acting β-agonists. Absence of SMART-specific asthma action plans emerged as a key barrier across care settings. CONCLUSION: Pediatric primary care clinicians endorse SMART therapy but face persistent clinician-, system-, and caregiver-level barriers to its implementation and to the deimplementation of short-acting β-agonists. Implementation strategies incorporating practice facilitation, audit and feedback, and electronic health record-generated SMART-specific asthma action plans may support more consistent uptake of pediatric guideline-concordant asthma care.

Authors

Institutions

Publication Details

Journal
PEDIATRICS
Published
2026-07-02
DOI
https://doi.org/10.1542/peds.2026-076324
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Barriers to Implementing SMART for Asthma in Pediatric Primary Care

Sherry Dodd, Julia Peled, James G. Krings, Allison A. King et al.
PEDIATRICS
Asthma and respiratory diseases
article

Barriers to Implementing SMART for Asthma in Pediatric Primary Care

Sherry Dodd, Julia Peled, James G. Krings, Allison A. King, Shannon Rook, Ruoyun Wang, S Graham, K Harris, Katie Plax, Aimee S. James
article en

Abstract

OBJECTIVES: To characterize awareness, use, and perceived barriers to implementing single maintenance and reliever therapy (SMART) in primary care for children aged 5 years or older, hypothesizing high clinician awareness but limited use due to multilevel clinician-, system-, and caregiver barriers. METHODS: We conducted a sequential explanatory mixed-methods study among pediatric primary care clinicians within a practice-based research network. Clinicians completed a survey assessing SMART awareness, prescribing practices, and perceived barriers, guided by the Consolidated Framework for Implementation Research (CFIR) 2.0. Semistructured interviews were conducted with purposively sampled clinicians to explore factors influencing SMART implementation. Qualitative data were analyzed using an inductive-deductive approach and mapped to CFIR 2.0 constructs. RESULTS: Fifty-two clinicians (27.5%) completed the survey, and 24 completed interviews. Awareness of SMART was universal, but use remained limited among eligible pediatric patients, particularly younger children. Clinicians viewed SMART as effective and guideline-concordant but described multilevel barriers to routine implementation. Qualitative analysis identified 3 themes: (1) SMART is clinically advantageous but challenging to operationalize; (2) system-level and workflow barriers, including insurance coverage and prior authorization requirements, constrain adoption; and (3) caregiver resistance impedes deimplementation of short-acting β-agonists. Absence of SMART-specific asthma action plans emerged as a key barrier across care settings. CONCLUSION: Pediatric primary care clinicians endorse SMART therapy but face persistent clinician-, system-, and caregiver-level barriers to its implementation and to the deimplementation of short-acting β-agonists. Implementation strategies incorporating practice facilitation, audit and feedback, and electronic health record-generated SMART-specific asthma action plans may support more consistent uptake of pediatric guideline-concordant asthma care.

PEDIATRICS
Nationwide Children's Hospital (US), Washington University in St. Louis (US), Saint Louis University (US)
Openalex Percentile: Top 9%
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.